Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7)-Reference-Cited by-同舟云学术

Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7)

Published:2017-07 Issue: Volume:398 Page:62-69
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Lin Shin-Jen,Chou Fu-Ju,Li Lei,Lin Chang-Yi,Yeh Shuyuan,Chang Chawnshang

Funder

NIH

Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference44 articles.

1. Innate or adaptive immunity? The example of natural killer cells;Vivier;Sci. (New York, N. Y.),2011

2. NK cell development, homeostasis and function: parallels with CD8(+) T cells, nature reviews;Sun;Immunology,2011

3. Antileukemia activity of a natural killer cell line against human leukemias;Yan;Clin. Cancer Res.,1998

4. Prospects for the use of NK cells in immunotherapy of human cancer, Nature reviews;Ljunggren;Immunology,2007

5. Natural killer cell lines in tumor immunotherapy;Cheng;Front. Med.,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide;Scientific Reports;2023-10-10

2. Non-coding RNAs: Emerging roles in the characterization of immune microenvironment and immunotherapy of prostate cancer;Biochemical Pharmacology;2023-08

3. Non-coding RNAs in enzalutamide resistance of castration-resistant prostate cancer;Cancer Letters;2023-07

4. Identification of bicalutamide resistance-related genes and prognosis prediction in patients with prostate cancer;Frontiers in Endocrinology;2023-04-18

5. Epigenetic modulation and prostate cancer: Paving the way for NK cell anti-tumor immunity;Frontiers in Immunology;2023-04-05